Stay updated on COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib
Sign up to get notified when there's something new on the COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib page.

Latest updates to the COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAddition of Revision: v3.3.2 and deletion of Revision: v3.2.0 are shown in the Record History.SummaryDifference0.0%

- Check20 days agoChange DetectedRemoved the funding-status notice that warned about possible delays in updates due to a lapse in government funding, including references to cc.nih.gov and opm.gov. No other substantive changes to the page content were observed.SummaryDifference0.2%

- Check34 days agoChange DetectedThe version history shows updates to the study status and recruitment status across multiple versions, with related changes to contacts/locations.SummaryDifference0.0%

- Check63 days agoChange Detected- Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.SummaryDifference7%

- Check70 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other substantive content changes.SummaryDifference0.2%

- Check77 days agoChange DetectedAdded a new study status results section (results) and a current date stamp; removed an older date placeholder. Overall, core page content and result information were updated.SummaryDifference0.9%

Stay in the know with updates to COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib
Enter your email address, and we'll notify you when there's something new on the COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib page.